NMR contribution to the understanding of multiple sclerosis;Apport de l'IRM a l'etude de la sclerose en plaques

Revue Neurologique

Volumn 153, Issue 12, 1997, Pages 754-770

  Grimaud, J ^a   Hermier, M ^b   Pachai, Ch ^c   Confavreux, Ch ^a  

^a Hopital de l'Antiquaille   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY;

HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0031440238     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (151)

1. ADAMS C.W.M (1977). Pathology of multiple sclerosis : progression of the lesion. Br Med Bull 33 : 15-20.
2. ALLEN I.V., MCKEOWN S.R. (1979). A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 41 : 81-91.
3. AMATO M.P., FRATIGLIONO L., GROPPI C., SIRACUSA G., AMADUCCI L. (1988). Interrater reliability in assessing functional systems and disability on the Kurtzke Scale in multiple sclerosis. Arch Neurol 45 : 746-748.
4. BARBOSA S., BLUMHARDT L.D., ROBERTS N., LOCK T., EDWARDS R.H.T. (1994). Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. Mag Reson Imaging 12 : 33-42.
5. BARKHOF F., SCHELTENS P., FREQUIN S.T.F.M., NAUTA J.J.P., TAS M.W., VALK J., HOMMES O.R. (1992). Relapsing-remitting MS: Sequential enhanced MR imaging vs. clinical findings in determining disease activity. Am J Roentgenol 159 : 1041-1047.
6. BARNES D., MCDONALD W.I., JOHNSON G., TOFTS P.S., LANDON D.N. (1987). Quantitative nuclear magnetic resonance imaging: Characterisation of experimental cerebral oedema. J Neurol Neurosurg Psychiatry 50 : 125-133.
7. BARNES D., MUNRO P.M.G., YOUL B.D., PRINEAS J.W., MCDONALD W.I. (1991). The longstanding MS lesion: a quantitative and electron microscopic study. Brain 114 : 1271-1280.
8. BASTIANELLO S., POZZILLI C., BERNARDI S., BOZZAO L., FANTOZZI L.M., BUTINELLI C., FIESCHI C. (1990). Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology 40 : 591-595.
9. BECK R.W., ARRINGTON J., MURTAGH F.R., CLEARY P.A., KAUFMAN D.I., OPTIC NEURITIS STUDY GROUP (1993). Brain magnetic resonance imaging in acute optic neuritis. Experience of the optic neuritis study group. Arch Neurol 50 : 841-846.
10. BEER S., ROSLER K.M., HESS C.W. (1995). Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria. J Neurol Neurosurg Psychiatry 59 : 152-159.
11. BOGGILD M.D., WILLIAMS R., HAQ N., HAWKINS C.P. (1996). Cortical plaques visualised by fluid-attenuated inversion recovery imaging in relapsing multiple sclerosis. Neuroradiol 38 : S10-13.
12. BOZZAO A, BASTIANELLO S, FERONE E, GIUGNI E, PAOLILLO A, BOZZAO L. (1996). Enhanced and unenhanced MR with magnetisation transfer in multiple sclerosis. AJNR Am J Neuroradiol 17 : 1837-1842.
13. BRAFFMAN B.H., ZIMMERMAN R.A., TROJANOWSKI J.Q., GONATAS N.K., HICKEY W.F., SCHLAEPFER W.W. (1988). Brain MR: Pathologic correlation with gross and histopathology. I. Lacunar infarction and Virchow-Robin spaces. Am J Roentgenol 151 : 551-558.
14. BROWN M.S., SIMON J.H., STEMMER S.M., STEARS J.C., SCHERZINGER A., CAGNONI P.J., JONES R.B. (1995). MR and proton spectroscopy of white matter disease induced by high-dose chemotherapy with bone marrow transplant in advanced breast carcinoma. AJNR Am J Neuroradiol 16 : 2013-2020.
15. BRUCK W., SCMIED M., SUCHANEK G., BRUCK Y., BREITSCHOPF H., POSER S., PIDDLESDEN S., LASSMANN H. (1994). Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 35 : 65-73.
16. CLINE H.E., LORENSEN W.E., KIKINIS R., JOLESZ F. (1990). Three-dimensional segmentation of MR images of the head using probability and connectivity. J Comput Assist Tomogr 14 : 1037-1045.
17. COLLINS D.L., NEELIN P., PETERS T.M., EVANS A.C. (1994). Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18 : 192-205.
18. CONFAVREUX C. (1995). Qu'attendre de l'interféron bêta dans la sclérose en plaques. La Revue du Praticien 45 : 1713-1715.
19. CONFAVREUX C., COMPSTON D.A.S., HOMMES O.R., MCDONALD W.I., THOMPSON A.J. (1992). EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 55 : 671-676.
20. CRUICKSHANK J.K., RUDGE P., DALGLEISH A.G., NEWTON M., MCLEAN B.N., BARNARD R.O., KENDALL B.E. (1989). Tropical spastic paraparesis and human T cell lymphotrapic virus Type 1 in the United Kingdom. Brain 112 : 1057-1090.
21. DAVIE C.A., BARKER G.J., WEBB S., MCDONALD W.I., MILLER D.H. (1994b). Proton magnetic resonance spectroscopy (MRS) study of cerebellar dysfunction in multiple sclerosis. J Neurol 241 (suppl 1) : S151.
22. DAVIE C.A., BARKER G.J., WEBB S., TOFTS P.S., THOMPSON A.J., HARDING A.E., MCDONALD W.I., MILLER D.H. (1995). Persistent neurological deficit in MS and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain 118 : 1582-1592.
23. DAVIE C.A., BARKER G.J., WEBB S., TOFTS P.S., THOMPSON A.J., MILLER D.H. (1996). A proton spectroscopy study of disability in multiple sclerosis. J Neurol 243 : S33
24. DAVIE C.A., HAWKINS C.P., BARKER G.J., BRENNAN A., TOFTS P.S., MILLER D.H., MCDONALD W.I. (1994a). Serial proton magnetic resonance spectroscopy in multiple sclerosis. Brain 117 : 49-58.
25. DE STEFANO N., MATTHEWS P.M., ANTEL J.P., PREUL M., FRANCIS G., ARNOLD D.-L. (1995). Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 38 : 901-909.
26. DE STEFANO N., PREUL M., MATTHEWS P.-M., FRANCIS G., ANTEL J.-P., ARNOLD D.-L. (1995a). Chemical-pathological changes detected by proton MR spectroscopy imaging in the brain of patients with an acute demyelinating plaque. Neurology 45 (suppl 4), A282.
27. DOUSSET V., ARMAND J.-P., DEGREZE P., MIEZE S., LAFON P., CAILLE J,-M. (1995a). Progressive multifocal leucoencephalopathy studied by magnetisation transfer imaging. Proc Soc Magn Reson 1, 284.
28. DOUSSET V., BROCHET B., VITAL A., GROSS C., BENAZZOUZ A., BOULLERNE A., BIDABE A.M., GIN A.M., CAILLE J.-M. (1995b). Lysolecithin-induced demyelination in primates : preliminary in vivo study with MR and magnetisation transfer. AJNR Am J Neuroradiol 16 : 225-231.
29. DOUSSET V., GROSSMAN R.I., RAMER K.N., SCHNALL M.D., YOUNG L.H., GONZALES-SCARANO F., LAVI E., COHEN J.A. (1992). Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetisation transfer imaging. Radiology 182 : 483-491. (erratum publié dans Radiology 1992; 183 : 878)
30. DRAYER B., BURGER P., HURWITZ B., DAWSON D., CAIN J. (1987). Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? Am J Neuroradiol 8 : 413-419.
31. EBERS C., VINUELA F.V., FEASBY T., BASS B. (1984). Multifocal CT enhancement in MS. Neurology 34 : 341-346.
32. EINSTEIN E.R., CSEJTEY J., DALAL K.B., ADAMS C.W.M., BAYLISS O.B., HALLPIKE J.-F. (1972). Proteolytic activity and basic protein loss in and around multiple sclerosis plaques. Combined biochemical and histochemical observations. J Neurochem 19 : 653-662.
33. EVANS A.C., FRANK J.A., ANTEL J., MILLER D.H. (1997). The role of MRI in clinical trials of multiple sclerosis: comparison of image processing techniques. Ann Neurol 41 : 125-132.
34. FAZEKAS F. (1989). Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol 29 : 164-168.
35. FAZEKAS F., OFFENBACHER H., FUCHS S., SCHMIDT R., NIEDERKERN K., HORNER S., LECHNER H. (1988). Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 38 : 1822-1825.
36. FILIPPI M., BARKER G.J., HORSFIELD M.A., SACARES P.R., MACMANUS D.G., THOMPSON A.J., TOFTS P.S., MCDONALD W.I., MILLER D.H. (1994b). Benign and secondary progressive multiple sclerosis : a preliminary quantitative MRI study. J Neurol 241 : 246-251.
37. FILIPPI M., CAMPI A., DOUSSET V., BAHATTI C., MATINELLI V., CANAL N., SCOTTI G., COMI G. (1995c). A magnetisation transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45 : 478-482.
38. FILIPPI M., CAMPI A., MARTINELLI V., COLOMBO B., YOUSRY T., CANAL N., SCOTTI G., COMI G.C. (1995a). Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 5 : 540-544.
39. FILIPPI M., HORSFIELD M.A., MORRISSEY S.P., MACMANUS D.G., RUDGE P., MCDONALD W.I., MILLER D.H. (1994a). Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 44 : 635-641.
40. FILIPPI M., HORSFIELD M.A., TOFTS P.S., BARKHOF F., THOMPSON A.J., MILLER D.H. (1995b). Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 118 : 1601-1612.
41. FRANKLIN G.M., HEATON R.K., NELSON L.M., FILLEY C.M., SEIBERT C. (1988). Correlations of neuropsychological and MRI findings in chronic-progressive multiple sclerosis. Neurology 38 : 1826-1829.
42. GASS A., BARKER G.J., KIDD D., THORPE J.W., MACMANUS D.G., BRENNAN A., TOFTS P.S., THOMPSON A.J., MCDONALD W.I., MILLER D.H. (1994). Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 36: 62-67.
43. GEAN-MARTON A.D., VENZIA L.G., MARTON K.I., STIMAC G.K., PEYSTER R.G., TAVERAS J.M., DAVIS K.R. (1991). Abnormal corpus callosum: A sensitive and specific indicator of multiple sclerosis. Radiology 180 : 215-221.
44. GERARD G., WEISBERG L.A. (1986). MRI periventricular lesions in adults. Neurology 36 : 998-1001.
45. GERSTL B., ENG L.F., TAVASTSTJERNA M., SMITH J.K., KRUSE S.L. (1970). Lipids and proteins in multiple sclerosis white matter. J Neurochem 17 : 677-689.
46. GILBERT J.J., SALDER M. (1983). Unsuspected multiple sclerosis. Arch Neurol 40 : 533-536.
47. GRAHAM G.D., ZHONG J., GUARNACCIA J.B., GORE J.C. (1995). Echoplanar imaging of water directional diffusion and diffusion anisotropy within multiple sclerosis plaques. Proc Soc Magn Reson 1 : 278.
48. GRIMAUD J., BARKER G.J., WANG L., LAI M., MACMANUS D.G., WEBB S.L., THOMPSON A.J., MCDONALD W.I., TOFTS P.S., MILLER D.H. (1996a). The correlation of multiparametric MRI measures with clinical disability in multiple sclerosis. A preliminary study. J Neurol 253 : 533.
49. GRIMAUD J., LAI M., THORPE J., ADELEINE P., WANG L., BARKER G.J., PLUMMER D.L, TOFTS P.S., MCDONALD W.I., MILLER D.H. (1996b). Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Mag Reson Imaging 14 : 495-505.
50. GRIMAUD J., MILLAR J., THORPE J.W., MOSELEY I.F., MCDONALD W.I., MILLER D.H. (1995). Signal intensity on MRI of basal ganglia in multiple sclerosis. J Neurol Neurosurg Psychiatry 59 : 306-308.
51. GROSSMAN R.I., GONZALEZ-SCARANO F., ATLAS S.W., GALETTA S., SILBERBERG D.H. (1986). Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 161 : 721-725.
52. HAJNAL J.V., BRYANT D.J., KASUBOSKI L, PATTANY P.M., DE COENE B., LEWIS P.D., PENNOCK J.M., OATRIDGE A., YOUNG I.R., BYDDER G.M. (1992). Use of fluid attenuated inversion recovery (FLAIR) pulse sequence in MRI of the brain. J Comput Assist Tomogr 16 : 841-844.
53. HARRIS J.O., FRANK J.A., PATRONAS N.J., MCFARLIN D.E., MCFARLAND H.F. (1991). Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 29 : 548-555.
54. HAUGHTON V.M., YETKIN F.Z., RAO S.M., RIMM A.A., FISCHER M.E., PAPKE R.A., BREGER R.K., KHATRI B.O. (1992). Quantitative MR in the diagnosis of multiple sclerosis. Mag Reson Med 26 : 71-78.
55. HOROWITZ A.L., KAPLAN R.D., GREWE G., WHITE R.T., SALBERG L.M. (1989). The ovoid lesion: A new observation in patients with MS. AJNR, Am J Neuroradiol 10 : 303-305.
56. ISAAC C., LI D.K., GENTON M., JARDINE C., GROWCHOWSKI E., PALMER M., KASTRUKOFF L.F., OGER J., PATY D.W. (1988). Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 38 : 1511-1515.
57. JACOBS L., MUNSCHAUSER F.E., KABA S.E. (1991). Clinical and magnetic resonance imaging in optic neuritis. Neurology 41 : 15-19.
58. JACOBS L.D., KABA S.E., MILLER C.M., PRIORE R.L., BROWNSCHEIDLE C.M. (1997). Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann Neurol 41 : 392-398.
59. KAPPOS L., STADT D., RATZKA M., KEIL W., SCHNEIDERBANGER-GRYGIER S., HEITZER T., POSER S., NADJMI M. (1988a). Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 30 : 299-302.
60. KAPPOS L, GOLD R., HOFMANN E., KEIL W., CLAUSS W. (1990). Multiple sclerosis: diagnostic criteria and the role of contrast enhanced MRI. In: Bydder GM, Felix R, Bucheler E, et al. (eds) Contrast media in MRI. Medicom Europe, Bussum : 127-135.
61. KAPPOS L., PATZOLD U., DOMMASCH D., POSER S., HAAS J., KRAUSENECK P., MALIN J.-P., FIERZ W., GRAFFENRIED B.D., GUGERLI U.S. (1988b). Cyclosoprine versus azathioprine in the long-term treatment of multiple sclerosis : results of the German multicentre study. Ann Neurol 23 : 56-63.
62. KAPPOS L., STADT D., RATZKA M., KEIL W., SCHNEIDERBANGER-GRYGIER S., HEITZER T., POSER S., NADJMI M. (1988a). Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 30 : 299-302.
63. KATZ D., TAUBENBERGER J., RAINE C., MCFARLIN D., MCFARLAND H. (1990). Gadolinium-enhancing lesions on magnetic resonance imaging: neuropathological findings. Ann Neurol 28 : 243.
64. KATZ D., TAUBENBERGER J.K., CANNELLA B., MCFARLIN D.E., RAINE C.S., MCFARLAND H.F. (1993). Correlation between magnetic resonance imaging findings and lesion development in multiple sclerosis. Ann Neurol 34 : 661-669.
65. KAZUI S., NARITOMI H., IMAKITA S., YAMADA N., OGAWA M., SAWADA T. (1991). Sequential gadolinium-DTPA enhanced MRI studies in neuro-Behcet's disease. Neuroradiology 33 : 136-139.
66. KERMODE A.G., THOMPSON A.J., TOFTS P.S., MACMANUS D.G., KENDALL B.E., KINGSLEY D.P.E., MCDONALD W.I. (1990a). Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 113 : 1477-1489.
67. KERMODE A.G., TOFTS P.S., THOMPSON A.J., MACMANUS D.G., RUDGE P., KENDALL B.E., KINGSLEY D.P.E., MOSELEY I.F, BOULAY E.P.G.H DU, MCDONALD W.I. (1990b). Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology 40 : 229-235.
68. KESSELRING J., MILLER D.H., ROBB S.A., KENDALL B.E., MOSELEY I.F., KINGSLEY D., DU BOULAY E.P.G.H., MCDONALD W.I. (1990). Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain 1990 : 291-302.
69. KIDD D., BARKER G.J., TOFTS P.S., GASS A., THOMPSON A.J., MCDONALD W.I., MILLER D.H. (1997). The transverse magnetisation decay characteristics of longstanding lesions and normal-appearing white matter in multiple sclerosis. J Neurol 244 : 125-130.
70. KIDD D., THORPE J.W., KENDALL B.E., BARKER G.J., MILLER D.H., MCDONALD W.I., THOMPSON A.J. (1996). MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 60 : 15-19.
71. KIDD D., THORPE J.W., THOMPSON A.J., KENDALL B.E., MOSELEY I.F., MACMANUS D.G., MCDONALD W.I., MILLER D.H. (1993). Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43 : 2632-2637.
72. KIRKPATRICK J.B., HAYMAN L.A. (1987). White-matter lesions in MR imaging of clinically healthy brains of elderly subjects: Possible pathological basis. Radiology 162 : 509-511.
73. KOOPMANS R.A., LI D.K.G., OGER J.F., KASTRUKOFF L.F., JARDINE C., COSTLEY L., HALL S., GROCHOWSKI E.W., PATY D.W. (1989). Chronic progressive multiple sclerosis: Serial magnetic resonance brain imaging over six months. Ann Neurol 26 : 248-256.
74. KURTZKE J.F. (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 : 1444-1452.
75. LANGOON D.W., GRIMAUD J., BARKER G.J., WANG L., LAI M., MACMANUS D.G., WEBB S.L., MCDONALD W.I., TOFTS P.S., MILLER D.H., THOMPSON A.J. (1996). The correlation of multiparameter MRI measures with cognitive dysfunction in multiple sclerosis, a preliminary study. Eur J Neurology 3 (suppl 4) : 60.
76. LARSSON H.B.V., FREDERIKSEN J., KYAER L., HENRIKSEN O., OLESEN J. (1988). In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med 7 : 43-55.
77. LEE K.H., HASHIMOTO S.A., HOOGE J.P., KASTRUKOFF L.F., OGER J.J.F., LI D.K.B., PATY D.W. (1991). Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potential, oligoclonal banding, and CT. Neurology 41 : 657-660.
78. Li H., DEKLERCK R., DE CUYPER B., HERMANUS A., NYSSEN E., CORNELIS J. (1995). Object recognition in brain CT-scan: knowledge-based fusion of data from multiple feature extractors. IEEE Transactions on Medical Imaging 14 : 212-229.
79. LOEVNER L.A., GROSSMAN R.I., MCGOWAN J.C., RAMER K.N., COHEN J.A. (1995). Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. AJNR Am J Neuroradiol 16 : 1473-1479.
80. LOSSEFF N.A., WANG L., LAI H.M., YOO D.S., GRAWNE-CAIN M.L., MCDONALD W.I., MILLER D.H., THOMPSON A.J. (1996a). Progressive cerebral atrophy in multiple sclerosis. Brain 119 : 2009-2019.
81. LOSSEFF N.A., WEBB S.L., O'RIORDAN J.I., PAGE R., WANG L., BARKER J., TOFTS P.S., MCDONALD W.I., MILLER D.H., THOMPSON A.J. (1996b). Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119 : 701-708.
82. LUKES S.A., CROOKS L.E., AMINOFF M.J., KAUFMAN L., PANITCH H.S., MILLS C., NORMAN D. (1983). Nuclear magnetic resonance imaging in multiple sclerosis. Ann Neurol 13 : 592-601.
83. MACKAY A., WHITTAL K., ADLER J., LI D., PATY D., GRAEB D. (1994). In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 31 : 673-677.
84. MCFARLAND H.F., FRANK J.A., ALBERT P.S., SMITH M.E., MARTIN R., HARRIS J.O., PATRONAS N., MALONI H., MCFARLIN D.E. (1992). Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 32 : 758-766.
85. MEHTA R.C., PIKE G.B., ENZMANN D.R. (1996). Measure of magnetisation transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and œdema. AJNR Am J Neuroradiol 17 : 1051-1055.
86. MILLER D.H., ALBERT P.S., BARKHOF F., FRANCIS G., FRANK J.A., HODGKINSON S., LUBLIN F.D., PATY D.W., REINGOLD S.C., SIMON J. (1996). Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurology 39 : 6-16.
87. MILLER D.H., BARKHOF F., NAUTA J.J.P. (1993). Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 116 : 1077-1094.
88. MILLER D.H., JOHNSON G., TOFTS P.S., MACMANUS D., MCDONALD W.I. (1989b). Precise relaxation time measurements of normal appearing white matter in inflammatory central nervous system disease. Magn Reson Med 11 : 331-336.
89. MILLER D.H., KENDALL B.E., BARTER S., JOHNSON G., MACMANUS D.G,. LOGSDAIL S.J., PSYCH M.R.C., ORMEROD I.E.C., MCDONALD W.I. (1988b). Magnetic resonance in central nervous system sarcoidosis. Neurology 38 : 378-383.
90. MILLER D.H., ORMEROD I.E.C., GIBSON A. et al. (1987). MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 29 : 226-231.
91. MILLER D.H., ORMEROD I.E.C., RUDGE P., KENDALL B.E., MOSELEY I.F., MCDONALD W.I. (1989). The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol 26 : 635-639.
92. MILLER D.H., RUDGE P., JOHNSON G., KENDALL B.E., MACMANUS D.G., MOSELEY I.F., BARNES D., MCDONALD W.I. (1988a). Serial Gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 111 : 927-939.
93. MOFFETT J.R., NAMBOODIRI M.A., CANGRO C.B., NEALE J.H. (1991). Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 2 : 131-134.
94. MOREAU T., THORPE J., MILLER D., MOSELEY I., HALE G., WALDMANN H., CLAYTON D., WING M. (1994). Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet 344 : 298-301.
95. MOREAU TH., HOURS M., COMI G., ADELEINE P., CONFAVREUX C., AND THE PRESTIMUS GROUP (1996). PRESTIMUS: predictive estimates in multiple sclerosis. A European multicentric prospective study. J Neurol 243 : S2.
96. MORISSEY S.P., MILLER D.H., KENDALL B.E., KINGSLEY D.P.E., KELLY M.A., FRANCIS D.A., MACMANUS D.G., MCDONALD W.I. (1993). The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 116 : 135-146.
97. NARAYANA P.A., WOLINSKY J.S., DOYLE T.J. Is perivenous inflammation an obligatory event for demyelinisation in multiple sclerosis? Serial magnetic resonance and spectroscopic imaging studies (submitted).
98. NARAYANAN S., FU L., PIORO E., DE STEFANO N., COLLINS D.L., FRANCIS G.S., ANTEL J.P., MATTHEWS P.M., ARNOLD D.L. (1997). Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 41 : 385-391.
99. NATIONAL MULTIPLE SCLEROSIS SOCIETY WORKING GROUP ON NEUROIMAGING FOR THE MEDICAL ADVISORY BOARD (1986). Use of magnetic resonance imaging in the diagnosis of multiple sclerosis: policy statement. Neurology 36 : 1575.
100. NOSEWORTHY J.H., VAN DER VOORT M.K., WONG C.J., EBERS G.C. (1990). Interrater variability with the expanded disability status scale (EDSS) and functional system (FS) in a multiple sclerosis clinical trial. Neurology 40 : 971-975.
101. O'CONNOR P.W., TANSEY C.M., DETSKY A.S., MUSHLIN A.I., KUCHARCZYK W. (1996). The effect of spectrum bias on the utility of magnetic resonance imaging and evoked potentials in the diagnosis of suspected multiple sclerosis. Neurology 47 : 140-144.
102. O'RIOROAN J.I., THOMPSON A.J., RUDGE P., MCDONALD W.I., MILLER D.H. (1996). The long term risk of multiple sclerosis following clinically isolated syndromes of the central nervous system. J Neurol 243 : S33.
103. OFFENBACHER H., FAZEKAS F., SCHMIDT R., FREIDL W., FLOOH E., PAYER F., LECHNER H. (1993). Assessment of brain MRI criteria for a diagnosis of MS. Neurology 43 : 905-909.
104. ORMEROD I.E.C., BRONSTEIN A., RUDGE P., JOHNSON G., MACMANUS D., HALLIDAY A.M., BARRATT H., DU BOULAY E.P.G.H., KENDALL B.E., MOSELEY I.F., JONES S.J., KRISS A., PERINGER E. (1986a). Magnetic resonance imaging in clinically isolated lesions of the brainstem. J Neurol Neurosurg Psychiatry 49 : 737-743.
105. ORMEROD I.E.C., JOHNSON G., MACMANUS D., DU BOULAY E.P.G.H., MCDONALD W.I. (1986b). Relaxation times of apparently normal cerebral white matter in multiple sclerosis. Acta Radiol 369 : 382-384.
106. ORMEROD I.E.G., MILLER D.H., MCDONALD W.I., BOULAY E.P.G.H. DU, RUDGE P., KENDALL B.E.W., MOSELEY I.F., JOHNSON G., TOFTS P.S., HALLIDAY A.M., BRONSTEIN A.M., SCARAVILLI F., HARDING A.E., BARNES D., ZILKHA K.J. (1987). The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 110 : 1579-1616.
107. PACHNER A.R., DURAY P., STEERE A.C. (1989). Central nervous system manifestations of Lyme disease. Arch Neurol 46 : 790-795.
108. PANNIZZO F., STALLMEYER M.J.B., FRIEDMAN J., JENNIS R.J., ZABRISKIE J., PLANK C., ZIMMERMAN R., WHALEN J.-P., CAHILL P.-T. (1992). Quantitative MRI studies for assessment of multiple sclerosis. Magn reson Med 24 : 90-99.
109. PATY D.W., LI D.K., OGER J.J.F., KASTRUKOFF L., KOOPMANS R., TANTON E., ZHAO G.J. (1994). Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 36 : S95-96.
110. PATY D.W., LI D.K.B., UBC MS/MRI STUDY GROUP (1993). Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43 : 662-667.
111. PATY D.W., OGER J.J.F., KASTRUKOFF L.F., HASHIMOTO S.A., HOOGE J.P., EISEN A.A., EISEN K.A., PURVES S.J., LOW M.D., BRANDEJS V., ROBERTSON W.D., LI D.K.B. (1988). MRI in the diagnosis of MS: A prospective study of comparison with clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38 : 180-185.
112. PELLETIER J., HABIB M., LYON-CAEN O., SALAMON G., PONCET M., KHALIL R. (1993). Functionnal and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis. Arch Neurol 50 : 1077-1082.
113. POSER C.M., PATY D.W., SCHEINBERG L., MCDONALD W.I., DAVIS S.A., EBERS G.C., JOHNSON K.P., SIBLEY W.A., SILBERBERG D.H., TOURTELLOTTE W.W. (1983). New diagnostic criteria for multiple sclerosis : Guidelines for research protocols. Ann Neurol 13 : 227-231.
114. POWELL T., SUSSMAN J.G., DAVIES-JONES G.A.B. (1992). MR imaging in acute multiple sclerosis: ringlike appearance in plaques suggesting the presence of paramagnetic free radicals. Am J Neuroradiol 13 : 1544-1546.
115. PRINEAS J.W., BARNARD R.O., KWON E.E., SHARER L.R., CHO E.S. (1993). Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 33 : 137-151.
116. PRINEAS J.W., KWON E.E., GOLDENBERG P.Z., ILYAS A.A., QUARLES R.H., BENJAMINS J.A., SPRINKLE T.J. (1989). Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 61 : 489-503.
117. RAINE C.S., SCHEINBERG L., WALTZ J.M. (1981). Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest 45 : 534-546.
118. RAO S.M., LEO G.J., HAUGHTON V.M., ST.-AUBIN-FAUBERT P., BERNARDIN L. (1989). Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 39 : 161-166.
119. REVESZ T., HAWKINS C.P., DU BOULAY E.P.G.H., BARNARD R.O., MCDONALD W.I. (1989). Pathological findings correlated with magnetic resonance imaging in subcortical arteriosclerotic encephalopathy (Binswanger's disease). J Neurol Neurosurg Psychiatry 52 : 1337-1344.
120. RICHARDS T.L. (1991). Proton MR spectroscopy in MS: Value in establishing diagnosis, monitoring progression, and evaluating therapy. AJR, Am J Roentgenol 157 : 1073-1078.
121. RON M.A., CALLANAN M.M., WARRIMGTON E.K. (1991). Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study. Psychol Med 21 : 59-68.
122. RUNGE V.M., PRICE A.C., KIRSHNER H.S., ALLEN J.H., PARTAIN C.L., JAMES A.E. (1984). Magnetic resonance imaging of multiple sclerosis: A study of pulse-technique efficiency. Am J Roentgenol 143 : 1015-1026.
123. SAPPEY-MARIMIER D. (1990). High-resolution NMR spectroscopy of cerebral white matter in multiple sclerosis. Mag Reson Med 15 : 229-239.
124. SCOTTI G., SCIALFI G., BIONDI A., LANDONI L., CAPUTO D., CAZZULO C.L. (1986). Magnetic resonance in MS. Neuroradiology 28 : 319-323.
125. SIMON J.H., SCHIFFER R.B., RUDICK R.A., HERNDON R.M. (1986). Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging. Am J Neuroradiol 8 : 599-604.
126. SMITH M.E., STONE L.A., ALBERT P.S., FRANK J.A., MARTIN R., ARMSTRONG M., MALONI H., MCFARLIN D.E., MCFARLAND H.F. (1993). Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 33 : 480-489.
127. STEWART W.A., HALL L.D., BERRY K., PATY D.W. (1984). Correlation between NMR scan and brain slice data in multiple sclerosis. Lancet 324 : 412.
128. STONE L.A., ALBERT P.S., SMITH M.E., DE CARLI C., ARMSTRONG M.R., MCFARLIN D.E., FRANK J.A., MCFARLAND H.F. (1995). Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis. Neurology 45 : 1808-1814.
129. TAS M.W., BARKHOL F., VAN WALDERVEEM M.A.A., POLMAN CH., HOMMES O.R., VALK J. (1995). The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. Am J Neuroradiol 16 : 259-264
130. THE IFNB MULTIPLE SCLEROSIS STUDY GROUP. (1993). Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Neurology 43 : 655-661.
131. THE IFNB STUDY GROUP. (1995). University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized, controlled trial. Neurology 45 : 1277-1285.
132. THOMPSON A.J., KERMODE A.G., WICKS D., MACMAMUS D.G., KENDALL B.E., KINGSLEY D.P.E., MCDONALD W.I. (1991). Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 29 : 53-62.
133. THOMPSON A.J., MILLER D., YOUL B., MACMAMUS D., MOORE S., KINGSLEY D., KENDALL B., FEINSTEIN A., MCDONALD W.I. (1992). Serial gadolinium enhanced MRI in relapsing-remitting multiple sclerosis of varying disease duration. Neurology 42 : 60-63.
134. THORPE J.W., BARKER G.J., JONES S.J., MOSELEY I., LOSSEFF N., MACMANUS D.G., WEBB S., MORTIMER C., PLUMMER D.L., TOFTS P.S., MCDONALD W.I., MILLER D.H. (1995). Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology. J Neurol Neurosurg Psychiatry 59 : 487-492.
135. THORPE J.W., KIDD D., KENDALL B.E., TOFTS P.S., BARKER G.J., THOMPSON A.J., MACMANUS D.G., MCDONALD W.I., MILLER D.H. (1993). Spinal cord MRI using multi-array coils and fast spin echo. I. Technical aspects and findings in healthy controls. Neurology 43 : 2625-2631.
136. THORPE J.W., KIDD D., MOSELEY I.F., KENDALL B.E., THOMPSON A.J., MACMANUS D.G., MCDONALD W.I., MILLER D.H. (1996). Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46 : 373-378.
137. THORPE J.W., MUMFORD C.J., COMPSTON D.A.S., KENDALL B.E., MACMANUS D.G., MCDONALD W.I., MILLER D.H. (1994). British Isles survey of multiple sclerosis in twins: MRI. J Neurol Neurosurg Psychiatry 57 : 491-96.
138. TRUYENI L., VAN WAESBERGHE J.H.T.M., VAN WALDERVEEN M.A.A., VAN OOSTEN B.W., POLMAN C.H., HOMMES O.R., ADER H.J.A., BARKHOF F. (1996). Accumulation of hypointense lesions ("black holes") on T1-weighted images of multiple sclerosis patients correlates with disease progression in secondary-progressive MS patients. Neurology 47 : 1469-1476.
139. UHLENBROCK D., SEHLEN S. (1989). The value of T1-weighted images in the differentiation between MS, white matter lesion, and subcortical arteriosclerotic encephalopathy (SAE). Neuroradiology 31 : 203-212.
140. VAN WALDERVEEN M.A.A., BARKHOF F., HOMMES O.R., POLMAN C.H., TOBI H., FREQUIN S.T.M.F., VALK J. (1995). Correlating MR imaging and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short TR/short TE ("T1-weighted") spin-echo images. Neurology 45 : 1684-1690.
141. VAN WALDERVEEN M.A.A., SCHELTENS P., BARKHOF F., RAVID R., POLMAN C.H., VALK J., KAMPHORST W. (1996). Histopathologic correlates of hypointense lesions on T1-weighted SE MR images in multiple sclerosis. J Neurol 243 : S18.
142. WANG L., THORPE J.W., TOFTS P.S. (1995). Evaluation of cluster analysis in multiple sclerosis lesion segmentation. Proceedings of the Society of Magnetic Resonance and the European Society for Magnetic Resonance in Medicine and Biology 2 : 709.
143. WHITAKER J.N., MCFARLAND H.F., RUDGE P., REINGOLD S.C. (1995). Outcomes assessment in multiple sclerosis clinical trials: A critical analysis. Multiple Sclerosis 1 : 37-47.
144. WICKS D.A.G., TOFTS P.S., MILLER D.H., DU BOULAY G.H., FEINSTEIN A., SACARES R.P., HARVEY I., BRENNER R., MCDONALD W.I. (1992). Volume measurement of multiple sclerosis lesions with magnetic resonance images. A preliminary study. Neuroradiology 34 : 475-479.
145. WIEBE S., LEE D.H., KARLICK S.J., HOPKINS M., VANDERVOORT M.K., WONG C.J., HEWITT L., RICE G.P.A., EBERS G.C., NOSEWORTHY J.H. (1992). Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol 32 : 643-650.
146. WILLOUGHBY E.W., GROCHOWSKI E., LI D.K.B., OGER J., KASTRUKOFF L.F., PATY D.W. (1989). Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 25 : 43-49.
147. WOLFF S.D., BALABAN R.S. (1989). Magnetisation transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Res Medecine 10 : 135-144.
148. WOLFF S.D., BALABAN R.S. (1994). Magnetisation transfer imaging: practical aspects and clinical applications. Radiology 192 : 593-599.
149. WOLINSKY J.S., NARAYANA P.A., DOYLE T.J., LINDSEY J.W., HUSTON T.X. (1995). Serial 2-D proton magnetic resonance spectroscopic imaging (MRSI) of MS. Neurology 45 (suppl 4) : A282.
150. YOUL B.D., TURANO G., MILLER D.H., TOWELL A.D., MACMANUS D.G., MOORE S.G., JONES S.J., BARRETT G., KENDALL B.E., MOSELEY I.F., TOFTS P.S., HALLIDAY A.M., MCDONALD W.I. (1991). The pathophysiology of acute optic neuritis: an association of gadolinium leakage with clinical and electrophysiological deficits. Brain 114 : 2437-2450.
151. YOUNG I.R., HALL A.S., PALLIS C.A., LEGG N.J., BYDDER G.M., STEINER R.E. (1981). Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 318 : 1063-1066.